NDWM LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Sell
227
-43
-16% -$43.6K 0.14% 35
2025
Q4
$290K Hold
270
0.19% 29
2025
Q3
$206K Hold
270
0.14% 33
2025
Q2
$210K Hold
270
0.15% 31
2025
Q1
$223K Hold
270
0.22% 29
2024
Q4
$208K Sell
270
-16
-6% -$13.2K 0.17% 31
2024
Q3
$253K Hold
286
0.21% 29
2024
Q2
$259K Hold
286
0.23% 29
2024
Q1
$222K Buy
+286
New +$204K 0.2% 30

Other funds holding LLY

NDWM LLC's LLY Position: Q1 2026 in Review

NDWM LLC reduced its Eli Lilly (LLY) stake by 16% in Q1 2026, selling an estimated $43.6K and leaving 227 shares worth $209K. The position accounts for 0.14% of the portfolio, ranked #35.

NDWM LLC first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $290K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NDWM LLC held 227 shares of Eli Lilly worth $209K as of Q1 2026.
  • NDWM LLC sold 43 Eli Lilly shares in Q1 2026, an estimated $43.6K.
  • Eli Lilly made up 0.14% of NDWM LLC's portfolio in Q1 2026, its #35 holding.
  • NDWM LLC first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • NDWM LLC's Eli Lilly position peaked at $290K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NDWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.